These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2442617)

  • 1. Phorbol ester and Epstein-Barr virus dependent transformation of normal primary human skin epithelial cells.
    Tomei LD; Noyes I; Blocker D; Holliday J; Glaser R
    Nature; 1987 Sep 3-9; 329(6134):73-5. PubMed ID: 2442617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
    Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
    Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of an Epstein-Barr-virus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells.
    Shao X; He Z; Chen Z; Yao K
    Int J Cancer; 1997 May; 71(5):750-5. PubMed ID: 9180141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.
    Niedobitek G; Agathanggelou A; Nicholls JM
    Semin Cancer Biol; 1996 Aug; 7(4):165-74. PubMed ID: 8946600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma.
    Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
    Anticancer Res; 2000; 20(6D):4909-16. PubMed ID: 11326639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma.
    Knox PG; Li QX; Rickinson AB; Young LS
    Virology; 1996 Jan; 215(1):40-50. PubMed ID: 8553585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
    Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
    Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus infection is associated with increased apoptosis in untreated and phorbol ester-treated human Burkitt's lymphoma (AW-Ramos) cells.
    Ishii HH; Gobé GC
    Biochem Biophys Res Commun; 1993 May; 192(3):1415-23. PubMed ID: 8389551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The transfection and morphological changes of human embryonic nasopharyngeal epithelia infected by Epstein-Barr virus cooperated with promoter in vitro and in vivo].
    Sun N; Chen X; Wu F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):70-3. PubMed ID: 12515178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
    Okano M
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution and characterization of environmental promoter substances as assayed by synergistic Epstein-Barr virus-activating system.
    Ito Y; Tokuda H; Ohigashi H; Koshimizu K
    Princess Takamatsu Symp; 1983; 14():125-37. PubMed ID: 6097577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
    Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
    J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
    Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
    J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.